About This Resource
Psilobase is an independent educational portal dedicated to evidence-based harm reduction around psilocybin mushrooms. Our team includes researchers, science writers, and harm-reduction practitioners who contribute on a volunteer basis. We are not affiliated with any pharmaceutical company, government body, or commercial supplier.
We cover species identification, microdosing protocols, safety and emergency procedures, research summaries, cultivation basics, and therapeutic integration — always with citations and clear caveats about legal status and personal risk.
How to Reach Us
Because Psilobase operates as an independent educational project without a customer-service infrastructure, we handle contact through a small shared inbox. Response times are typically 5–10 business days. Please read the guidance below before writing so we can route your message efficiently.
Corrections and Factual Errors
Accuracy is our highest priority. If you find a factual error — an incorrect dosage figure, an outdated legal status, a misattributed study — please include:
- The page URL and the specific passage in question
- The correction you believe is needed
- A credible source (peer-reviewed study, official government page, or recognised harm-reduction organisation)
We review all substantiated corrections and publish updates promptly. Corrections are welcomed and valued — no attribution is required unless you want it.
Feedback and Suggestions
We welcome feedback on readability, accessibility, missing topics, confusing wording, or anything that makes the site harder to use. Suggestions for new topics or sections are particularly appreciated; our editorial backlog is shaped largely by reader requests.
Academic and Research Collaboration
Researchers wishing to flag new findings, request a link correction, or discuss a collaboration for harm-reduction content may write with a brief description of their institutional affiliation and the nature of the collaboration. We aim to reflect current science as accurately as possible, and peer-reviewed input is always welcome.
Media and Press
Journalists and documentary makers are welcome to quote from the site with attribution. If you need clarification on a specific piece of content, or would like to interview a member of our editorial team, please write with your publication name and deadline. We respond to press enquiries within 48 hours where possible.
What We Cannot Help With
To keep our volunteers focused on editorial work, there are several areas we are not able to assist with:
- Medical advice: We cannot interpret symptoms, suggest dosing for a specific individual, or advise on drug interactions. Please consult a qualified healthcare professional for personal medical questions.
- Legal advice: Legal status of psilocybin varies enormously by jurisdiction. We cannot advise on whether a specific activity is legal in your location. Consult a solicitor or attorney.
- Sourcing or procurement: We do not stock, sell, or endorse suppliers of any substance.
- Species identification: Misidentification of mushrooms can be fatal. We do not perform identifications from photographs or descriptions; please consult a professional mycologist or local expert.
- Crisis support: If you or someone you know is in a mental health crisis, please contact emergency services or a crisis line immediately (see below).
Crisis and Mental Health Support
This site cannot provide real-time support. If you are experiencing a difficult psychedelic experience or a mental health crisis, please reach out to a trained professional:
- Fireside Project (US psychedelic crisis support): 623-473-7433 — free, confidential, available daily 3 pm–3 am PT
- Samaritans (UK and Ireland): 116 123 — free, 24 hours
- Crisis Text Line (US/UK): Text HOME to 741741
- Emergency services: Call 999 (UK) or 911 (US) for medical emergencies
Disclaimer
All content on Psilobase is provided for educational and informational purposes only. Nothing on this site constitutes medical, legal, or professional advice. Psilocybin is a controlled substance in most jurisdictions; users are solely responsible for understanding and complying with the laws in their location. Psilobase does not encourage or facilitate illegal activity.
Frequently Asked Questions
Who runs Psilobase?
Psilobase is maintained by an independent team of researchers, science writers, and harm-reduction practitioners. We are not affiliated with any pharmaceutical company, government body, or commercial supplier of substances.
Is Psilobase affiliated with any organisation?
Psilobase is an independent project. While our content draws on research from institutions such as Johns Hopkins, NYU, and MAPS, we have no formal affiliation with any external organisation.
How long does it take to get a response?
We aim to respond within 5–10 business days for general feedback and corrections, and within 48 hours for press enquiries. We are a small volunteer team, so we appreciate your patience.
Can I contribute an article or guide?
Yes. We welcome contributions from researchers, practitioners, and experienced educators. Write to us with a brief outline, your background, and the topic you want to cover. All submissions are reviewed for accuracy before publication.
How do I report a broken link or technical issue?
Include the page URL and a description of the problem. Technical issues are typically fixed within a few days of being reported.
Can I reuse content from Psilobase?
Educational reuse with attribution is generally fine. Commercial reproduction, reposting in full without attribution, or use in contexts that could mislead readers about the source is not permitted. When in doubt, write to us first.
Does Psilobase track my personal data?
We use minimal, anonymised analytics to understand which sections are most useful. We do not collect or sell personally identifiable information. See our Privacy Policy for full details.